Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: A Department of Defense experience

American Surgeon

Volumn 80, Issue 6, 2014, Pages 595-599

  Reha, Jeffrey L ^a   Lee, Sukhyung ^b   Hofmann, Luke J ^c  

^a BLANCHFIELD ARMY COMMUNITY HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BARIATRIC SURGERY; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GOVERNMENT; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIVER BIOPSY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PREDICTIVE VALUE; PREVALENCE; RETROSPECTIVE STUDY; BIOPSY; BLOOD; CONFIDENCE INTERVAL; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; FOLLOW UP; LIVER; LIVER FUNCTION TEST; METHODOLOGY; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICS; UNITED STATES;

ADULT; ASPARTATE AMINOTRANSFERASES; BARIATRIC SURGERY; BIOPSY; BODY MASS INDEX; CONFIDENCE INTERVALS; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; OBESITY, MORBID; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF DEFENSE;

EID: 84904874834     PISSN: 00031348     EISSN: 15559823     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kowdley K, Caldwell S. Nonalcoholic steatohepatitis: a twenty-first century epidemic? J Clin Gastroenterol 2006;40:S2-4.
2. Matteoni C, Younossi Z, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1998;116:1413-9.
3. Ludwig J, Viggiano T, McGill D, et al. Nonalcoholic steatohepatits: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
4. Ong J, Younossi Z. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease. Clin Liver Dis 2005;9:617-34.
5. Ogden C, Carroll M, Curtin L, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-55.
6. Falck-Ytter Y, Younossi Z, Marchesini G, et al. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:17-26.
7. Wanless I, Lentz J. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12:1106-10.
8. Moretto M, Kupski C, Mottn C, et al. Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. Obes Surg 2003;11:622-4.
9. Crespo J, Fernandez-Gil P, Hernandez-Guerra M, et al. Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis? Obes Surg 2001;11:254-7.
10. Harnois F, Msika S, Sabate J, et al. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery. Obes Surg 2006;16:183-8.
11. Dixon J, Bhathal P, O'Brien P. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
12. Boza C, Riquelme A, Ibanez L, et al. Predictors of non-alcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes Surg 2005;15:1148-53.
13. Beymer C, Kowdley K, Larson A, et al. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg 2003;138:1240-4.
14. Arun J, Clements R, Lazenby A, et al. The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Obes Surg 2006;16:1351-8.
15. Ong J, Elariny H, Collantes R, et al. Predictors of non-alcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 2005;15:310-5.
16. Spaulding L, Trainer T, Janiec D. Prevalence of non-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass. Obes Surg 2003;13:347-9.
17. Harrison S, Torgeson S, Hayashi P. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003;98:2042-7.
18. Fassio E, Alvarez E, Dominguez N, et al. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 2004;40:820-6.
19. Poonawala A, Nair S, Thuluvath P. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000;32:689-92.
20. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-40.
21. Brunt E, Janney C, Bisceglie A, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74.
22. Mofrad P, Contos M, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37:1286-92.
23. Nguyen N, Magno C, Lane K, et al. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999-2004. J Am Coll Surg 2008;207:928-34.
24. Haque M, Sanyal A. The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 2002;16:709-31.
25. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005;143:722-8.
26. Marchensini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23.
27. Kadayifci A, Merriman R, Bass N. Medical treatment of non-alcoholic steatohepatitis. Clin Liver Dis 2007;11:119-40.
28. Barker K, Palekar N, Bowers S, et al. Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. Am J Gastroenterol 2006;101:368-73.